Status:
TERMINATED
Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD)
Lead Sponsor:
CoMentis
Conditions:
Macular Degeneration
Eligibility:
All Genders
50+ years
Phase:
PHASE2
Brief Summary
This is a Phase II randomized, double-masked study comparing the safety and efficacy of ATG003 (mecamylamine HCl) 1.0% and 0.3% ophthalmic solutions to placebo in patients with neovascular ("wet") age...
Eligibility Criteria
Inclusion
Exclusion
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
343 Patients enrolled
Trial Details
Trial ID
NCT00414206
Start Date
March 1 2007
End Date
September 1 2009
Last Update
November 23 2010
Active Locations (42)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Olhos de Araraquara
Araraquara, Brazil
2
Centro Brasileiro de Ciências Visuais
Belo Horizonte, Brazil
3
Instituto da Visão
Belo Horizonte, Brazil
4
Centro Brasileiro de Cirurgia dos Olhos
Goiânia, Brazil